Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma-Reference-Cited by-同舟云学术

Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma

Published:2007-04-15 Issue:8 Volume:109 Page:1646-1653
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Seibel Nita L.,Krailo Mark,Chen Zhengjia,Healey John,Breitfeld Philip P.,Drachtman Richard,Greffe Brian,Nachman James,Nadel Helen,Sato Judith K.,Meyers Paul A.,Reaman Gregory H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

2. Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

3. Carboplatin/Ifosfamide Window Therapy for Osteosarcoma: Results of the St Jude Children’s Research Hospital OS-91 Trial

4. Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.

5. Neoadjuvant Chemotherapy for Patients with Synchronous Multifocal Osteosarcoma: Results in Eleven Cases

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depletion of chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance;2024-06-08

2. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments;International Journal of Molecular Sciences;2022-03-30

3. Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?;Journal of Adolescent and Young Adult Oncology;2021-08-02

4. State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma;Expert Opinion on Pharmacotherapy;2021-06-11

5. Current Treatment Considerations for Osteosarcoma Metastatic at Presentation;Orthopedics;2020-09